<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>2504-3145</journal-id>
<journal-title><![CDATA[Portuguese Journal of Public Health]]></journal-title>
<abbrev-journal-title><![CDATA[Port J Public Health]]></abbrev-journal-title>
<issn>2504-3145</issn>
<publisher>
<publisher-name><![CDATA[Escola Nacional de Saúde Pública]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S2504-31452022000100007</article-id>
<article-id pub-id-type="doi">10.1159/000522220</article-id>
<title-group>
<article-title xml:lang="en"><![CDATA[Implementing an online program to change benzodiazepine prescription: protocol of a hybrid type 1 cluster-randomised trial]]></article-title>
<article-title xml:lang="pt"><![CDATA[Implementação de um programa online para alteração da prescrição de benzodiazepinas: Protocolo de um estudo híbrido de tipo 1 randomizado por clusters]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Reis]]></surname>
<given-names><![CDATA[Teresa]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Serra]]></surname>
<given-names><![CDATA[Helena]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Azeredo]]></surname>
<given-names><![CDATA[Sofia]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
<xref ref-type="aff" rid="Aaf"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Xavier]]></surname>
<given-names><![CDATA[Miguel]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Universidade Nova de Lisboa Nova Medical School Comprehensive Health Research Centre (CHRC)]]></institution>
<addr-line><![CDATA[Lisbon ]]></addr-line>
<country>Portugal</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,Universidade NOVA de Lisboa NOVA School of Social Sciences and Humanities Interdisciplinary Centre of Social Sciences (CICS.NOVA)]]></institution>
<addr-line><![CDATA[Lisbon ]]></addr-line>
<country>Portugal</country>
</aff>
<aff id="Af3">
<institution><![CDATA[,Universidade Nova de Lisboa NOVA Medical School Comprehensive Health Research Centre (CHRC)]]></institution>
<addr-line><![CDATA[Lisbon ]]></addr-line>
<country>Portugal</country>
</aff>
<aff id="Af4">
<institution><![CDATA[,Universidade Nova de Lisboa NOVA Medical School EpiDoC Unit, CEDOC]]></institution>
<addr-line><![CDATA[Lisbon ]]></addr-line>
<country>Portugal</country>
</aff>
<aff id="Af5">
<institution><![CDATA[,Universidade Nova de Lisboa NOVA Medical School Mental Health Department]]></institution>
<addr-line><![CDATA[Lisbon ]]></addr-line>
<country>Portugal</country>
</aff>
<pub-date pub-type="pub">
<day>30</day>
<month>04</month>
<year>2022</year>
</pub-date>
<pub-date pub-type="epub">
<day>30</day>
<month>04</month>
<year>2022</year>
</pub-date>
<volume>40</volume>
<numero>1</numero>
<fpage>7</fpage>
<lpage>16</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://scielo.pt/scielo.php?script=sci_arttext&amp;pid=S2504-31452022000100007&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.pt/scielo.php?script=sci_abstract&amp;pid=S2504-31452022000100007&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.pt/scielo.php?script=sci_pdf&amp;pid=S2504-31452022000100007&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="en"><p><![CDATA[Abstract  Introduction:  Excessive benzodiazepine (BZD) prescription has long been considered a serious mental health concern in many countries. Many interventions using different methodologies have been implemented to change BZD prescription patterns in primary health care settings, with limited positive results.  Objectives:  The primary objective of our study was to analyse the effectiveness and implementation process of an intervention aimed at changing BZD prescription patterns in a primary health care setting in Portugal.  Methodology:  We chose as methodology an effectiveness-implementation hybrid type 1 intervention. Our intervention was based on the development of an online platform, named ePrimaPrescribe, which was delivered using a Digital Behaviour Change Intervention (DBCI), using a two-arm cluster-randomised clinical trial. Results: We primarily aimed to evaluate the effectiveness of our DBCI in changing BZD prescription patterns using the frequency of BZD prescriptions issued per month as an outcome measure. Secondarily, we aimed to analyse the effect of ePrimaPrescribe on antidepressant prescriptions, to study the effect of the platform on diagnosis registration associated with BZDs and antidepressant prescription, and to perform a cost analysis considering the monthly National Health Service spending on BZD co-payments. Finally, we aimed to analyse the implementation process using quantitative and qualitative methods.  Conclusion:  With this study, we expect to contribute with a cost-effective intervention to change the complex matter of excessive BZD prescriptions, and also to improve insight into the challenges to intervention implementation processes in primary health care settings. We believe that our findings are relevant not only to the specific setting where the study was implemented, but also to all countries where primary health care plays a central role in care provision.]]></p></abstract>
<abstract abstract-type="short" xml:lang="pt"><p><![CDATA[Resumo  Introdução:  A prescrição excessiva de benzodiazepinas (BZD) tem vindo a ser considerada como uma preocupação para a saúde mental em muitos países. Intervenções usando diferentes metodologias têm vindo a ser implementadas para mudar os padrões de prescrição de BZDs nos cuidados de saúde primários, com resultados positivos limitados. Objetivos: O objetivo principal do nosso estudo foi analisar a eficácia e o processo de implementação de uma intervenção que visa alterar os padrões de prescrição de BZDs em contexto dos cuidados de saúde primários.  Metodologia:  Escolhemos como metodologia um estudo híbrido de tipo 1 para avaliação da eficácia-implementação da intervenção. A intervenção foi baseada no desenvolvimento de uma plataforma online, chamada ePrimaPrescribe, que foi implementada através de uma Intervenção Digital para Mudança de Comportamento, recorrendo a um estudo randomizado por clusters.  Resultados:  O objetivo principal foi avaliar a eficácia da intervenção na mudança dos padrões de prescrição de BZD usando a frequência das prescrições de BZDs emitidas por mês como medida de resultado. Secundariamente, pretendemos analisar o efeito do ePrimaPrescribe nas prescrições de antidepressivos, estudar o efeito da plataforma no registo de diagnósticos associado à prescrição de BZDs e de antidepressivos, e realizarmos uma análise de custo considerando os gastos mensais do Serviço Nacional de Saúde com a comparticipação das BZDs. Por fim, analisámos o processo de implementação recorrendo a métodos quantitativos e qualitativos.  Conclusão:  Com este estudo, esperamos contribuir com uma intervenção custo-efetiva que contribua para mudar a complexa problemática da prescrição excessiva de BZDs, mas também contribuir para melhorar a compreensão dos desafios para os processos de implementação de intervenções no contexto dos cuidados de saúde primários. Acreditamos que os nossos resultados são relevantes não apenas para o contexto específico no qual o estudo foi implementado, mas para todos os países onde os cuidados de saúde primários desempenhem um papel central na prestação de cuidados.]]></p></abstract>
<kwd-group>
<kwd lng="en"><![CDATA[Benzodiazepines]]></kwd>
<kwd lng="en"><![CDATA[Prescription]]></kwd>
<kwd lng="en"><![CDATA[Digital Behaviour Change Intervention]]></kwd>
<kwd lng="en"><![CDATA[Primary health care]]></kwd>
<kwd lng="pt"><![CDATA[Benzodiazepinas]]></kwd>
<kwd lng="pt"><![CDATA[Prescrição]]></kwd>
<kwd lng="pt"><![CDATA[Intervenção Digital para Mudança de Comportamento]]></kwd>
<kwd lng="pt"><![CDATA[Cuidados de Saúde Primários]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lader]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Benzodiazepines revisited will we ever learn?]]></article-title>
<source><![CDATA[Addiction]]></source>
<year>2011</year>
<volume>106</volume>
<numero>12</numero>
<issue>12</issue>
<page-range>2086-109</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Brandt]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Leong]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Benzodiazepines and Z-drugs: an updated review of major adverse outcomes reported on in epidemiologic research]]></article-title>
<source><![CDATA[Drugs R D]]></source>
<year>2017</year>
<volume>17</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>493-507</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Khong]]></surname>
<given-names><![CDATA[TP]]></given-names>
</name>
<name>
<surname><![CDATA[De Vries]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Goldenberg]]></surname>
<given-names><![CDATA[JSB]]></given-names>
</name>
<name>
<surname><![CDATA[Klungel]]></surname>
<given-names><![CDATA[OH]]></given-names>
</name>
<name>
<surname><![CDATA[Robinson]]></surname>
<given-names><![CDATA[NJ]]></given-names>
</name>
<name>
<surname><![CDATA[Ibáñez]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Potential impact of benzodiazepine use on the rate of hip fractures in five large European countries and the United States]]></article-title>
<source><![CDATA[Calcif Tissue Int]]></source>
<year>2012</year>
<volume>91</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>24-31</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Donnelly]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Bracchi]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Hewitt]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Routledge]]></surname>
<given-names><![CDATA[PA]]></given-names>
</name>
<name>
<surname><![CDATA[Carter]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Benzodiazepines, Z-drugs and the risk of hip fracture: a systematic review and meta-analysis]]></article-title>
<source><![CDATA[PLoS One]]></source>
<year>2017</year>
<volume>12</volume>
<numero>4</numero>
<issue>4</issue>
</nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Thomas]]></surname>
<given-names><![CDATA[RE]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Benzodiazepine use and motor vehicle accidents: a systematic review of reported association]]></article-title>
<source><![CDATA[Can Fam Physician]]></source>
<year>1998</year>
<volume>44</volume>
<page-range>799</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Carlsten]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Waern]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Holmgren]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Allebeck]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The role of benzodiazepines in elderly suicides]]></article-title>
<source><![CDATA[Scand J Public Health]]></source>
<year>2003</year>
<volume>31</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>224-8</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Neutel]]></surname>
<given-names><![CDATA[CI]]></given-names>
</name>
<name>
<surname><![CDATA[Patten]]></surname>
<given-names><![CDATA[SB]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Risk of suicide attempts after benzodiazepine and/or antidepressant use]]></article-title>
<source><![CDATA[Ann Epidemiol]]></source>
<year>1997</year>
<volume>7</volume>
<numero>8</numero>
<issue>8</issue>
<page-range>568-74</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cato]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Holländare]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Nordenskjöld]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Sellin]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Association between benzodiazepines and suicide risk a matched case-control study]]></article-title>
<source><![CDATA[BMC Psychiatry]]></source>
<year>2019</year>
<volume>19</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>317</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kurko]]></surname>
<given-names><![CDATA[TA]]></given-names>
</name>
<name>
<surname><![CDATA[Saastamoinen]]></surname>
<given-names><![CDATA[LK]]></given-names>
</name>
<name>
<surname><![CDATA[Tahkapaa]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Tuulio-Henriksson]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Taiminen]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Tiihonen]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Long-term use of benzodiazepines definitions, prevalence and usage patterns: a systematic review of register-based studies]]></article-title>
<source><![CDATA[Eur Psychiatry]]></source>
<year>2015</year>
<volume>30</volume>
<numero>8</numero>
<issue>8</issue>
<page-range>1037-47</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cullinan]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[O'Mahony]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Fleming]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Byrne]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[A meta-synthesis of potentially inappropriate prescribing in older patients]]></article-title>
<source><![CDATA[Drugs Aging]]></source>
<year>2014</year>
<volume>31</volume>
<numero>8</numero>
<issue>8</issue>
<page-range>631-8</page-range></nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="book">
<collab>NICE</collab>
<source><![CDATA[Benzodiazepine and Z drug withdrawal]]></source>
<year>2013</year>
<publisher-loc><![CDATA[London ]]></publisher-loc>
<publisher-name><![CDATA[National Institute for Health and Care Excellence]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="book">
<collab>American Psychiatric Association</collab>
<source><![CDATA[Diagnostic and statistical manual of mental disorders: DSM-5]]></source>
<year>2013</year>
<publisher-loc><![CDATA[Washington ]]></publisher-loc>
<publisher-name><![CDATA[American Psychiatric Association]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Stahl]]></surname>
<given-names><![CDATA[SM]]></given-names>
</name>
<name>
<surname><![CDATA[Stahl]]></surname>
<given-names><![CDATA[SM]]></given-names>
</name>
</person-group>
<source><![CDATA[Stahl's essential psychopharmacology: neuroscientific basis and practical applications]]></source>
<year>2013</year>
<publisher-loc><![CDATA[Cambridge ]]></publisher-loc>
<publisher-name><![CDATA[Cambridge University Press]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="book">
<collab>International Narcotics Control Board</collab>
<source><![CDATA[Report of the International Narcotics Control Board 2004: 2005]]></source>
<year>2005</year>
<publisher-loc><![CDATA[Vienna ]]></publisher-loc>
<publisher-name><![CDATA[International Narcotics Control Board]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="book">
<collab>Observatório Português dos Sistemas de Saúde</collab>
<source><![CDATA[Relatório da primavera: novo serviço público de saúde: novos desafios]]></source>
<year>2005</year>
<publisher-loc><![CDATA[Coimbra ]]></publisher-loc>
<publisher-name><![CDATA[Mar da Palavra]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="book">
<collab>Caldas de Almeida JMJ.Xavier M</collab>
<source><![CDATA[Estudo epidemiologico nacional de saúde mental: 1° relatório]]></source>
<year>2013</year>
<publisher-loc><![CDATA[Lisbon ]]></publisher-loc>
<publisher-name><![CDATA[Nova Medical School]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Furtado]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Teixeira]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Utilização de benzodiazepinas em Portugal continental 1999-2003]]></article-title>
<source><![CDATA[Acta Med Port]]></source>
<year>2006</year>
<volume>19</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>239-46</page-range></nlm-citation>
</ref>
<ref id="B18">
<label>18</label><nlm-citation citation-type="book">
<collab>Portugal Ministério da SaúdeDireção Geral da Saúde</collab>
<source><![CDATA[Programa nacional saúde mental. Saúde mental em números 2013]]></source>
<year>2013</year>
<publisher-loc><![CDATA[Lisbon ]]></publisher-loc>
<publisher-name><![CDATA[Direção Geral da Saúde]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B19">
<label>19</label><nlm-citation citation-type="book">
<collab>Portugal Ministério da SaúdeDireção Geral da Saúde</collab>
<source><![CDATA[Programa nacional saúde mental. Saúde mental em números 2014]]></source>
<year>2014</year>
<publisher-loc><![CDATA[Lisbon ]]></publisher-loc>
<publisher-name><![CDATA[Direcção Geral da Saúde]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B20">
<label>20</label><nlm-citation citation-type="book">
<collab>Portugal Ministério da SaúdeDireção Geral da Saúde</collab>
<source><![CDATA[Plano nacional de saúde 2012-2016: indicadores e metas em saúde]]></source>
<year>2016</year>
<publisher-loc><![CDATA[Lisbon ]]></publisher-loc>
<publisher-name><![CDATA[Direcção Geral da Saúde]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B21">
<label>21</label><nlm-citation citation-type="book">
<collab>Portugal Ministério da SaúdeDireção Geral da Saúde</collab>
<source><![CDATA[Plano nacional de saúde: revisão e extensão a 2020]]></source>
<year>2015</year>
<publisher-loc><![CDATA[Lisboa ]]></publisher-loc>
<publisher-name><![CDATA[Direcção Geral da Saúde]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B22">
<label>22</label><nlm-citation citation-type="book">
<collab>INFARMED</collab>
<source><![CDATA[Análise de consumo de medicamentos em meio ambulatório]]></source>
<year>2020</year>
<publisher-loc><![CDATA[Lisbon ]]></publisher-loc>
<publisher-name><![CDATA[Infarmed]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B23">
<label>23</label><nlm-citation citation-type="book">
<collab>INFARMED</collab>
<source><![CDATA[Benzodiazepinas e análogos 2016]]></source>
<year>2017</year>
<publisher-loc><![CDATA[Lisbon ]]></publisher-loc>
<publisher-name><![CDATA[Infarmed]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B24">
<label>24</label><nlm-citation citation-type="journal">
<collab>De las Cuevas C.Sanz E.De la Fuente JA.Cabrera C.Mateos A</collab>
<article-title xml:lang=""><![CDATA[Prescribed daily doses and "risk factors" associated with the use of benzodiazepines in primary care]]></article-title>
<source><![CDATA[Pharmacoepidemiol Drug Saf]]></source>
<year>1999</year>
<volume>8</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>207-16</page-range></nlm-citation>
</ref>
<ref id="B25">
<label>25</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cormack]]></surname>
<given-names><![CDATA[MA]]></given-names>
</name>
<name>
<surname><![CDATA[Sweeney]]></surname>
<given-names><![CDATA[KG]]></given-names>
</name>
<name>
<surname><![CDATA[Hughes-Jones]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Foot]]></surname>
<given-names><![CDATA[GA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Evaluation of an easy, cost-effective strategy for cutting benzodiazepine use in general practice]]></article-title>
<source><![CDATA[Br J Gen Pract]]></source>
<year>1994</year>
<volume>44</volume>
<numero>378</numero>
<issue>378</issue>
<page-range>5-8</page-range></nlm-citation>
</ref>
<ref id="B26">
<label>26</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gorgels]]></surname>
<given-names><![CDATA[WJMJ]]></given-names>
</name>
<name>
<surname><![CDATA[Voshaar]]></surname>
<given-names><![CDATA[RCO]]></given-names>
</name>
<name>
<surname><![CDATA[Mol]]></surname>
<given-names><![CDATA[AJJ]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Discontinuation of long-term benzodiazepine use by sending a letter to users in family practice a prospective controlled intervention study]]></article-title>
<collab>van de Lisdonk EH.van Balkom AJLM.van den Hoogen HJM</collab>
<source><![CDATA[Drug Alcohol Depend]]></source>
<year>2005</year>
<volume>78</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>49-56</page-range></nlm-citation>
</ref>
<ref id="B27">
<label>27</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bueno]]></surname>
<given-names><![CDATA[MB]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Benzocarta intervención mínima para la desprescripción de benzodiacepinas en pacientes con insomnio]]></article-title>
<collab>de Velasco Artaza ER.Uria JF.Iturbe AG</collab>
<source><![CDATA[Gac Sanit]]></source>
<year>2019</year>
<volume>34</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>539-45</page-range></nlm-citation>
</ref>
<ref id="B28">
<label>28</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Richards]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Toop]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Graham]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Do clinical practice education groups result in sustained change in GP prescribing]]></article-title>
<source><![CDATA[Fam Pract]]></source>
<year>2003</year>
<volume>20</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>199-206</page-range></nlm-citation>
</ref>
<ref id="B29">
<label>29</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Vicens]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Bejarano]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Sempere]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Mateu]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Fiol]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Socias]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Comparative efficacy of two interventions to discontinue long-term benzodiazepine use cluster randomised controlled trial in primary care]]></article-title>
<source><![CDATA[Br J Psychiatry]]></source>
<year>2014</year>
<volume>204</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>471-9</page-range></nlm-citation>
</ref>
<ref id="B30">
<label>30</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Baker]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Farooqi]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Tait]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Walsh]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Randomised controlled trial of reminders to enhance the impact of audit in general practice on management of patients who use benzodiazepines]]></article-title>
<source><![CDATA[Qual Health Care]]></source>
<year>1997</year>
<volume>6</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>14-8</page-range></nlm-citation>
</ref>
<ref id="B31">
<label>31</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kollen]]></surname>
<given-names><![CDATA[BJ]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Discontinuation of reimbursement of benzodiazepines in the Netherlands does it make a difference?]]></article-title>
<collab>van der Veen WJ.Groenhof F.Donker GA.van der Meer K</collab>
<source><![CDATA[BMC Fam Pract]]></source>
<year>2012</year>
<volume>13</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>111</page-range></nlm-citation>
</ref>
<ref id="B32">
<label>32</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gentile]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Lapeyre-Mestre]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Micallef]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Combatting the misuse of benzodiazepines and related Z drugs in French general practice: a clinical review]]></article-title>
<source><![CDATA[BJGP Open]]></source>
<year>2020</year>
<volume>4</volume>
<numero>1</numero>
<issue>1</issue>
</nlm-citation>
</ref>
<ref id="B33">
<label>33</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Arensman]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Coffey]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Griffin]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Van Audenhove]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Scheerder]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Gusmao]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Effectiveness of depression-suicidal behaviour gatekeeper training among police officers in three European regions outcomes of the Optimising Suicide Prevention Programmes and their implementation in Europe (OSPI-Europe) study]]></article-title>
<source><![CDATA[Int J Soc Psychiatry]]></source>
<year>2016</year>
<volume>62</volume>
<numero>7</numero>
<issue>7</issue>
<page-range>651-60</page-range></nlm-citation>
</ref>
<ref id="B34">
<label>34</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Sketris]]></surname>
<given-names><![CDATA[IS]]></given-names>
</name>
<name>
<surname><![CDATA[Ingram]]></surname>
<given-names><![CDATA[EML]]></given-names>
</name>
<name>
<surname><![CDATA[Lummis]]></surname>
<given-names><![CDATA[HL]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Strategic opportunities for effective optimal prescribing and medication management]]></article-title>
<source><![CDATA[J Popul Ther Clin Pharmacol]]></source>
<year>2009</year>
<volume>16</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>e103-25</page-range></nlm-citation>
</ref>
<ref id="B35">
<label>35</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Whyte]]></surname>
<given-names><![CDATA[SR]]></given-names>
</name>
<name>
<surname><![CDATA[Van der Geest]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Hardon]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<source><![CDATA[Social lives of medicines]]></source>
<year>2002</year>
<publisher-loc><![CDATA[Cambridge ]]></publisher-loc>
<publisher-name><![CDATA[Cambridge University Press]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B36">
<label>36</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Abraham]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Pharmaceuticalization of society in context theoretical, empirical and health dimensions]]></article-title>
<source><![CDATA[Sociology]]></source>
<year>2010</year>
<volume>44</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>603-22</page-range></nlm-citation>
</ref>
<ref id="B37">
<label>37</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Curran]]></surname>
<given-names><![CDATA[GM]]></given-names>
</name>
<name>
<surname><![CDATA[Bauer]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Mittman]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Pyne]]></surname>
<given-names><![CDATA[JM]]></given-names>
</name>
<name>
<surname><![CDATA[Stetler]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Effectiveness-implementation hybrid designs combining elements of clinical effectiveness and implementation research to enhance public health impact]]></article-title>
<source><![CDATA[Med Care]]></source>
<year>2012</year>
<volume>50</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>217</page-range></nlm-citation>
</ref>
<ref id="B38">
<label>38</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Pisco]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Primary healthcare reform in Portugal on two fronts autonomous family healthcare units and management of groupings of Health Centers]]></article-title>
<source><![CDATA[Cien Saúde Colet]]></source>
<year>2011</year>
<volume>16</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>2841</page-range></nlm-citation>
</ref>
<ref id="B39">
<label>39</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Pinto]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
</person-group>
<source><![CDATA[Modifying factors for drug prescription behaviour in Primary Care]]></source>
<year>2017</year>
<publisher-loc><![CDATA[Lisbon ]]></publisher-loc>
<publisher-name><![CDATA[Nova Medical School, NOVA University Lisbon]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B40">
<label>40</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Reis]]></surname>
<given-names><![CDATA[TA]]></given-names>
</name>
</person-group>
<source><![CDATA[Change in prescribing patterns of benzodiazepines after training of general practitioners]]></source>
<year>2015</year>
<publisher-loc><![CDATA[Lisbon ]]></publisher-loc>
<publisher-name><![CDATA[NOVA Medical School, NOVA University Lisbon]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B41">
<label>41</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rutterford]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Copas]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Eldridge]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Methods for sample size determination in cluster randomized trials]]></article-title>
<source><![CDATA[Int J Epidemiol]]></source>
<year>2015</year>
<volume>44</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>1051-67</page-range></nlm-citation>
</ref>
<ref id="B42">
<label>42</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Eldridge]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Kerry]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<source><![CDATA[A practical guide to cluster randomised trials in health services research]]></source>
<year>2012</year>
<publisher-loc><![CDATA[Hoboken ]]></publisher-loc>
<publisher-name><![CDATA[John Wiley &amp; Sons]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B43">
<label>43</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Michie]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Van Stralen]]></surname>
<given-names><![CDATA[MM]]></given-names>
</name>
<name>
<surname><![CDATA[West]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The behaviour change wheel a new method for characterising and designing behaviour change interventions]]></article-title>
<source><![CDATA[Implement Sci]]></source>
<year>2011</year>
<volume>6</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>42</page-range></nlm-citation>
</ref>
<ref id="B44">
<label>44</label><nlm-citation citation-type="book">
<collab>Portugal Ministério da SaúdeDireção Geral da Saúde</collab>
<source><![CDATA[Norma de orientação clínica no. 055/2011, de 27/10/2011, atualizada a 21/01/2015: tratamento sintomático da ansiedade e insónia com benzodiazepinas e fármacos análogos]]></source>
<year>2015</year>
<publisher-loc><![CDATA[Lisbon ]]></publisher-loc>
<publisher-name><![CDATA[Direção Geral da Saúde]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B45">
<label>45</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Pottie]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Thompson]]></surname>
<given-names><![CDATA[W]]></given-names>
</name>
<name>
<surname><![CDATA[Davies]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Grenier]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Sadowski]]></surname>
<given-names><![CDATA[CA]]></given-names>
</name>
<name>
<surname><![CDATA[Welch]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Deprescribing benzodiazepine receptor agonists]]></article-title>
<source><![CDATA[Can Fam Physician]]></source>
<year>2018</year>
<volume>64</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>339-51</page-range></nlm-citation>
</ref>
<ref id="B46">
<label>46</label><nlm-citation citation-type="book">
<collab>All Wales Medicines Strategy Group</collab>
<source><![CDATA[Educational pack: material to support appropriate prescribing of hypnotics and anxiolytics across wales]]></source>
<year>2016</year>
<publisher-loc><![CDATA[Penarth ]]></publisher-loc>
<publisher-name><![CDATA[All Wales Therapeutics and Toxicology Centre]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B47">
<label>47</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cardoso]]></surname>
<given-names><![CDATA[RM]]></given-names>
</name>
</person-group>
<source><![CDATA[Competências clínicas de comunicação]]></source>
<year>2018</year>
<publisher-loc><![CDATA[Porto ]]></publisher-loc>
<publisher-name><![CDATA[Afrontamento]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B48">
<label>48</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hoffmann]]></surname>
<given-names><![CDATA[TC]]></given-names>
</name>
<name>
<surname><![CDATA[Glasziou]]></surname>
<given-names><![CDATA[PP]]></given-names>
</name>
<name>
<surname><![CDATA[Boutron]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Milne]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Perera]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Moher]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Better reporting of interventions template for intervention description and replication (TIDieR) checklist and guide]]></article-title>
<source><![CDATA[BMJ]]></source>
<year>2014</year>
<volume>348</volume>
<page-range>g1687</page-range></nlm-citation>
</ref>
<ref id="B49">
<label>49</label><nlm-citation citation-type="book">
<collab>WHO Collaborating Centre for Drug Statistics Methodology</collab>
<source><![CDATA[Guidelines for ATC classification and DDD assignment 2017]]></source>
<year>2016</year>
<publisher-loc><![CDATA[Oslo ]]></publisher-loc>
<publisher-name><![CDATA[WHO]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B50">
<label>50</label><nlm-citation citation-type="book">
<collab>World Organization of Family Doctors (WONCA)</collab>
<collab>International Classification Committee (WICC)</collab>
<source><![CDATA[International classification of primary care: ICPC-2]]></source>
<year>2017</year>
<edition>2nd</edition>
<publisher-loc><![CDATA[Oslo ]]></publisher-loc>
<publisher-name><![CDATA[Directorate of eHealth]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B51">
<label>51</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Harmsen]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Peters]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Wensing]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<source><![CDATA[Room for improvement? Barriers and facilitators assessment instrument: introduction, instructions and instrument. Nijmegen:]]></source>
<year>2002</year>
<publisher-loc><![CDATA[Centre for Quality of Care Research(WOK) ]]></publisher-loc>
<publisher-name><![CDATA[Radboud University Nijmegen Medical Centre]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B52">
<label>52</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Agresti]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<source><![CDATA[An introduction to categorical data analysis]]></source>
<year>2018</year>
<publisher-loc><![CDATA[Hoboken ]]></publisher-loc>
<publisher-name><![CDATA[John Wiley &amp; Sons]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B53">
<label>53</label><nlm-citation citation-type="book">
<collab>R Core Team</collab>
<source><![CDATA[R: a language and environment for statistical computing]]></source>
<year>2019</year>
<publisher-loc><![CDATA[Vienna ]]></publisher-loc>
<publisher-name><![CDATA[The R Foundation]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B54">
<label>54</label><nlm-citation citation-type="book">
<collab>RStudio Team</collab>
<source><![CDATA[RStudio: integrated development for R]]></source>
<year>2015</year>
<publisher-loc><![CDATA[Boston ]]></publisher-loc>
<publisher-name><![CDATA[RStudio]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B55">
<label>55</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Wickham]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
</person-group>
<source><![CDATA[ggplot2: elegant graphics for data analysis]]></source>
<year>2009</year>
<publisher-loc><![CDATA[Dordrecht ]]></publisher-loc>
<publisher-name><![CDATA[Springer]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B56">
<label>56</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hwang]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Utilizing qualitative data analysis software a review of Atlas.ti]]></article-title>
<source><![CDATA[Soc Sci Comput Rev]]></source>
<year>2008</year>
<volume>26</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>519-27</page-range></nlm-citation>
</ref>
<ref id="B57">
<label>57</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kuckartz]]></surname>
<given-names><![CDATA[U]]></given-names>
</name>
</person-group>
<source><![CDATA[Qualitative text analysis: a guide to methods, practice and using software]]></source>
<year>2014</year>
<publisher-loc><![CDATA[London ]]></publisher-loc>
<publisher-name><![CDATA[Sage]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B58">
<label>58</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Green]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Thorogood]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
</person-group>
<source><![CDATA[Qualitative methods for health research]]></source>
<year>2018</year>
<edition>3</edition>
<publisher-loc><![CDATA[London ]]></publisher-loc>
<publisher-name><![CDATA[Sage]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B59">
<label>59</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Vicens]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Socias]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Mateu]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Leiva]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Bejarano]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Sempere]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Comparative efficacy of two primary care interventions to assist withdrawal from long term benzodiazepine use a protocol for a clustered, randomized clinical trial]]></article-title>
<source><![CDATA[BMC Fam Pract]]></source>
<year>2011</year>
<volume>12</volume>
<numero>1</numero>
<issue>1</issue>
</nlm-citation>
</ref>
<ref id="B60">
<label>60</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Michie]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Johnston]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Abraham]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Lawton]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Parker]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Walker]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Making psychological theory useful for implementing evidence based practice a consensus approach]]></article-title>
<source><![CDATA[Qual Saf Health Care]]></source>
<year>2005</year>
<volume>14</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>26-33</page-range></nlm-citation>
</ref>
<ref id="B61">
<label>61</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Pinto]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Heleno]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Rodrigues]]></surname>
<given-names><![CDATA[DS]]></given-names>
</name>
<name>
<surname><![CDATA[Papoila]]></surname>
<given-names><![CDATA[AL]]></given-names>
</name>
<name>
<surname><![CDATA[Santos]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Caetano]]></surname>
<given-names><![CDATA[PA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[An open cluster-randomized, 18-month trial to compare the effectiveness of educational outreach visits with usual guideline dissemination to improve family physician prescribing]]></article-title>
<source><![CDATA[Implement Sci]]></source>
<year>2014</year>
<volume>9</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>10</page-range></nlm-citation>
</ref>
<ref id="B62">
<label>62</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Michie]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[West]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<source><![CDATA[A guide to development and evaluation of digital behaviour change interventions in healthcare]]></source>
<year>2016</year>
<publisher-loc><![CDATA[Sutton ]]></publisher-loc>
<publisher-name><![CDATA[Silverback]]></publisher-name>
</nlm-citation>
</ref>
</ref-list>
</back>
</article>
